# ğŸ§¬ Computational Drug Discovery Suite

[![Python](https://img.shields.io/badge/Python-3.9+-blue.svg)](https://python.org)
[![PyTorch](https://img.shields.io/badge/PyTorch-2.0+-red.svg)](https://pytorch.org)
[![RDKit](https://img.shields.io/badge/RDKit-2023+-orange.svg)](https://rdkit.org)
[![PyG](https://img.shields.io/badge/PyTorch_Geometric-2.0+-green.svg)](https://pytorch-geometric.readthedocs.io)
[![License](https://img.shields.io/badge/License-MIT-yellow.svg)](LICENSE)

> **A comprehensive computational drug discovery platform combining pharmacophore-based virtual screening with Graph Attention Networks**

This repository showcases an end-to-end drug discovery pipeline that integrates:
- ğŸ”¬ **Multi-metric molecular similarity** (Morgan, 2D/3D Pharmacophore)
- ğŸ§  **Deep Learning** with Graph Attention Networks (GAT)
- âš›ï¸ **Quantum Chemistry** features from DFT calculations
- ğŸ“Š **Interactive dashboards** for real-time analysis

---

## ğŸ“‘ Table of Contents

- [Overview](#-overview)
- [Key Features](#-key-features)
- [Pipeline Architecture](#-pipeline-architecture)
- [Drug Screening Pipeline](#-drug-screening-pipeline)
  - [Interactive Property Filter](#-interactive-property-filter)
  - [Drug Screener Dashboard](#-drug-screener-dashboard)
  - [Similarity Metrics](#-similarity-metrics-explained)
- [Graph Attention Network](#-graph-attention-network-for-binding-prediction)
  - [Architecture](#gat-architecture)
  - [Attention Mechanism](#understanding-attention-weights)
  - [DFT Feature Integration](#dft-feature-integration)
- [Interactive Dashboards](#-interactive-dashboards)
  - [DrugQuest Dashboard](#drugquest-dashboard)
  - [GAT-Specific Analysis Dashboard](#gat-specific-analysis-dashboard)
- [Installation](#-installation)
- [Usage](#-usage)
- [Results](#-results)
- [Project Structure](#-project-structure)

---

## ğŸ¯ Overview

This project implements a **two-stage computational drug discovery workflow** targeting **COX-2 inhibitors** (anti-inflammatory drugs):

```
â”Œâ”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”
â”‚                         DRUG DISCOVERY PIPELINE                             â”‚
â”œâ”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”¤
â”‚                                                                             â”‚
â”‚   STAGE 1: Virtual Screening Pipeline (drug_screening-5.ipynb)             â”‚
â”‚   â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€             â”‚
â”‚   â€¢ Drug-likeness filtering (Lipinski, Veber, Lead-like)                   â”‚
â”‚   â€¢ Multi-metric similarity (Morgan, Pharm2D, Pharm3D)                     â”‚
â”‚   â€¢ Consensus scoring and candidate ranking                                 â”‚
â”‚   â€¢ Interactive visualization and exploration                               â”‚
â”‚                                                                             â”‚
â”‚                              â†“                                              â”‚
â”‚                                                                             â”‚
â”‚   STAGE 2: Deep Learning Binding Prediction (gat_multitask_binding.ipynb)  â”‚
â”‚   â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€    â”‚
â”‚   â€¢ Graph Attention Network with DFT features                               â”‚
â”‚   â€¢ Multi-task learning for pharmacophore prediction                        â”‚
â”‚   â€¢ Attention-based interpretability                                        â”‚
â”‚   â€¢ COX-2 binding site pharmacophore scoring                               â”‚
â”‚                                                                             â”‚
â””â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”˜
```

---

## âœ¨ Key Features

| Feature | Description |
|---------|-------------|
| **ğŸ” Multi-Metric Screening** | Combines Morgan fingerprints, 2D/3D pharmacophore similarity |
| **âš›ï¸ DFT Integration** | Quantum chemical features (Fukui indices, ESP, charges) |
| **ğŸ§  Graph Attention Networks** | State-of-the-art GNN with interpretable attention |
| **ğŸ“Š Interactive Dashboards** | 4 comprehensive dashboards for analysis |
| **ğŸ¯ COX-2 Specific** | Pharmacophore requirements from PDB structure 4PH9 |
| **ğŸ“ˆ Consensus Scoring** | Weighted multi-metric candidate ranking |

---

## ğŸ—ï¸ Pipeline Architecture

### High-Level Overview

```
                    â”Œâ”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”
                    â”‚  SMILES Dataset  â”‚
                    â”‚   (185 drugs)    â”‚
                    â””â”€â”€â”€â”€â”€â”€â”€â”€â”¬â”€â”€â”€â”€â”€â”€â”€â”€â”€â”˜
                             â”‚
              â”Œâ”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”´â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”
              â–¼                              â–¼
â”Œâ”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”    â”Œâ”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”
â”‚   SCREENING PIPELINE    â”‚    â”‚    GNN PIPELINE         â”‚
â”œâ”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”¤    â”œâ”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”¤
â”‚ â€¢ RDKit Parsing         â”‚    â”‚ â€¢ Graph Construction    â”‚
â”‚ â€¢ Drug-likeness Filter  â”‚    â”‚ â€¢ Node Features (43d)   â”‚
â”‚ â€¢ Similarity Analysis   â”‚    â”‚ â€¢ Edge Features (5d)    â”‚
â”‚ â€¢ Consensus Scoring     â”‚    â”‚ â€¢ GAT Training          â”‚
â””â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”¬â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”˜    â””â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”¬â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”˜
            â”‚                              â”‚
            â–¼                              â–¼
â”Œâ”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”    â”Œâ”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”
â”‚  Drug Screener Dashboard â”‚    â”‚   DrugQuest Dashboard   â”‚
â”‚  â€¢ Radar Comparison     â”‚    â”‚   â€¢ Binding Scores      â”‚
â”‚  â€¢ 3D Pharmacophore     â”‚    â”‚   â€¢ Atom Importance     â”‚
â”‚  â€¢ Shape Alignment      â”‚    â”‚   â€¢ Chemistry Analysis  â”‚
â””â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”˜    â””â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”˜
```

---

## ğŸ”¬ Drug Screening Pipeline

The screening pipeline (`drug_screening-5.ipynb`) implements a comprehensive virtual screening workflow that filters and ranks drug candidates using multiple orthogonal metrics.

### ğŸ“Š Interactive Property Filter

The **Interactive Property Filter** is a powerful widget-based tool for real-time molecule filtering based on drug-likeness criteria.

![Interactive Property Filter](assets/interactive_property_filter.png)

#### Filter Components

| Component | Description | Purpose |
|-----------|-------------|---------|
| **Property Sliders** | MW, LogP, TPSA, QED, HBD, HBA | Continuous property filtering |
| **Rule Checkboxes** | Lipinski, Veber, Lead-like | Binary rule compliance |
| **Similarity Scores** | Morgan, Pharm2D, Pharm3D, Consensus | Reference-based filtering |
| **Distribution Plots** | Real-time histograms | Visual feedback |
| **Molecule Table** | Sortable results | Detailed inspection |

#### Drug-Likeness Rules Implemented

```
â”Œâ”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”
â”‚                      DRUG-LIKENESS FILTERING RULES                         â”‚
â”œâ”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”¤
â”‚                                                                            â”‚
â”‚  LIPINSKI'S RULE OF FIVE (1997)                                           â”‚
â”‚  â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€                                          â”‚
â”‚  Predicts oral bioavailability. Pass if â‰¥4 criteria met:                  â”‚
â”‚                                                                            â”‚
â”‚    â”Œâ”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”¬â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”¬â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â” â”‚
â”‚    â”‚ Property        â”‚ Threshold  â”‚ Rationale                           â”‚ â”‚
â”‚    â”œâ”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”¼â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”¼â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”¤ â”‚
â”‚    â”‚ Molecular Weightâ”‚ â‰¤ 500 Da   â”‚ Small enough for membrane passage   â”‚ â”‚
â”‚    â”‚ LogP            â”‚ â‰¤ 5        â”‚ Balanced lipophilicity              â”‚ â”‚
â”‚    â”‚ H-Bond Donors   â”‚ â‰¤ 5        â”‚ Limited desolvation penalty         â”‚ â”‚
â”‚    â”‚ H-Bond Acceptorsâ”‚ â‰¤ 10       â”‚ Limited desolvation penalty         â”‚ â”‚
â”‚    â””â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”´â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”´â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”˜ â”‚
â”‚                                                                            â”‚
â”‚  VEBER'S RULES (2002)                                                     â”‚
â”‚  â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€                                                     â”‚
â”‚  Predicts intestinal permeability:                                        â”‚
â”‚                                                                            â”‚
â”‚    â€¢ Rotatable Bonds â‰¤ 10  â†’  Molecular flexibility constraint            â”‚
â”‚    â€¢ TPSA â‰¤ 140 Ã…Â²         â†’  Polar surface area limit                    â”‚
â”‚                                                                            â”‚
â”‚  LEAD-LIKE CRITERIA (Teague, 1999)                                        â”‚
â”‚  â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€                                        â”‚
â”‚  More stringent for early-stage optimization:                             â”‚
â”‚                                                                            â”‚
â”‚    â€¢ MW â‰¤ 450              â†’  Room for chemical optimization              â”‚
â”‚    â€¢ LogP â‰¤ 4.5            â†’  Lower lipophilicity                         â”‚
â”‚    â€¢ Rotatable Bonds â‰¤ 7   â†’  Reduced flexibility                         â”‚
â”‚                                                                            â”‚
â””â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”˜
```

#### QED Score (Quantitative Estimate of Drug-likeness)

The QED score (Bickerton et al., 2012) provides a single [0-1] score combining 8 properties:

$$QED = \exp\left(\frac{1}{n}\sum_{i=1}^{n} \ln d_i\right)$$

Where $d_i$ are desirability functions for MW, LogP, HBA, HBD, TPSA, RotBonds, Rings, and Alerts.

---

### ğŸ›ï¸ Drug Screener Dashboard

The **Drug Screener Dashboard** is a comprehensive 8-tab interactive tool for exploring screening results with real-time molecular visualization.

![Drug Screener Dashboard - Radar](assets/drug_screener_radar.png)

#### Dashboard Tabs

| Tab | Function | Key Features |
|-----|----------|--------------|
| **ğŸ•¸ï¸ Radar Comparison** | Multi-candidate property comparison | 4-way radar charts, similarity metrics |
| **ğŸ§Š 3D Viewer** | Interactive molecular visualization | py3Dmol, multiple styles, rotation |
| **ğŸ”„ Shape Alignment** | 3D molecular overlay | RMSD calculation, shape similarity |
| **ğŸ§¬ 3D Pharmacophore** | Pharmacophore feature visualization | Color-coded spheres, feature comparison |
| **ğŸ”¬ Pharm Grid** | Multi-molecule pharmacophore grid | Top N hits visualization |
| **ğŸ“ˆ Similarity Heatmap** | Pairwise similarity matrix | Clustering patterns |
| **ğŸ“Š Properties** | Detailed property analysis | Property distributions |
| **ğŸ“‹ Data Explorer** | Tabular data exploration | Sorting, filtering, export |

#### Feature Highlights

**Radar Comparison View**
![Radar Comparison](assets/drug_screener_radar.png)
- Compare up to 4 candidates against reference
- Visualize similarity across multiple metrics
- Identify pharmacophore matches

**3D Molecular Viewer**
![3D Viewer](assets/drug_screener_3d_viewer.png)
- Interactive py3Dmol visualization
- Multiple rendering styles (Ball & Stick, Stick, Sphere)
- Property overlay

**Shape Alignment**
![Shape Alignment](assets/drug_screener_alignment.png)
- O3A alignment algorithm
- RMSD and shape similarity metrics
- Color-coded reference vs candidate

**3D Pharmacophore Comparison**
![3D Pharmacophore](assets/drug_screener_pharmacophore.png)
- Side-by-side pharmacophore visualization
- Feature-type color coding
- Feature count comparison

**Pharmacophore Grid View**
![Pharm Grid](assets/drug_screener_pharm_grid.png)
- Multiple candidates in grid layout
- Quick visual comparison
- Pharmacophore feature overlay

**Data Explorer**
![Data Explorer](assets/drug_screener_data_explorer.png)
- Complete scoring breakdown
- Top hits by each metric
- Exportable results

---

### ğŸ“ Similarity Metrics Explained

The pipeline uses **three complementary similarity metrics** to capture different aspects of molecular similarity:

#### 1. Morgan/ECFP Fingerprints (2048-bit)

Extended Connectivity Fingerprints capture **circular substructures** around each atom:

```
        Radius 0          Radius 1          Radius 2 (ECFP4)
           C                C-C               C-C-C
           â”‚                 â”‚                  â”‚
         (atom)         (+ neighbors)    (+ 2nd neighbors)
           â†“                 â†“                  â†“
        [hashâ‚€]          [hashâ‚]           [hashâ‚‚]
                              
                    Final: 2048-bit vector
```

**Use Case**: Chemical series identification, finding close analogs

#### 2. 2D Pharmacophore Fingerprints (Gobbi-Pharm2D)

Encodes **pharmacophore feature pairs** with their **topological distances**:

```
    Feature A â”€â”€â”€â”€ n bonds â”€â”€â”€â”€ Feature B
        â”‚                           â”‚
    (Donor)                    (Acceptor)
        â””â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”¬â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”˜
                      â†“
              Key: (D, A, n)
```

**Use Case**: Bioisostere discovery, scaffold hopping

#### 3. 3D Pharmacophore Fingerprints (Custom)

Encodes **spatial feature pairs** with **Euclidean distance bins**:

```
â”Œâ”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”
â”‚                3D PHARMACOPHORE PIPELINE                    â”‚
â”œâ”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”¤
â”‚                                                             â”‚
â”‚  3D Molecule (DFT coords)                                   â”‚
â”‚         â†“                                                   â”‚
â”‚  Feature Detection (RDKit SMARTS)                          â”‚
â”‚         â†“                                                   â”‚
â”‚  â”Œâ”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”   â”‚
â”‚  â”‚ Feature List:                                       â”‚   â”‚
â”‚  â”‚   â€¢ Donor    @ (1.2, 3.4, 5.6)                     â”‚   â”‚
â”‚  â”‚   â€¢ Acceptor @ (4.5, 2.1, 3.2)                     â”‚   â”‚
â”‚  â”‚   â€¢ Aromatic @ (2.0, 1.0, 4.0)                     â”‚   â”‚
â”‚  â””â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”˜   â”‚
â”‚         â†“                                                   â”‚
â”‚  Pairwise Distance Calculation                             â”‚
â”‚         â†“                                                   â”‚
â”‚  Distance Binning:                                         â”‚
â”‚    Bin 0: 0-2Ã…   â”‚ Bin 1: 2-4Ã…   â”‚ Bin 2: 4-6Ã…           â”‚
â”‚    Bin 3: 6-8Ã…   â”‚ Bin 4: 8-12Ã…  â”‚ Bin 5: 12-20Ã…         â”‚
â”‚         â†“                                                   â”‚
â”‚  Fingerprint: {(Type1, Type2, Bin): Count}                 â”‚
â”‚                                                             â”‚
â””â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”˜
```

**Use Case**: Binding mode prediction, 3D-QSAR

#### Tanimoto Similarity

All fingerprints use **Tanimoto coefficient** for comparison:

$$T(A, B) = \frac{|A \cap B|}{|A \cup B|} = \frac{c}{a + b - c}$$

#### Consensus Scoring

The final ranking uses **weighted consensus**:

$$\text{Consensus} = w_1 \cdot \text{Morgan} + w_2 \cdot \text{Pharm2D} + w_3 \cdot \text{Pharm3D}$$

| Strategy | Weights | Use Case |
|----------|---------|----------|
| **Balanced** | 0.33, 0.33, 0.34 | General screening |
| **Structural** | 0.6, 0.2, 0.2 | Close analog search |
| **Functional** | 0.2, 0.2, 0.6 | Scaffold hopping |

---

## ğŸ§  Graph Attention Network for Binding Prediction

The second pipeline (`gat_multitask_binding.ipynb`) uses **Graph Attention Networks** to predict binding compatibility with the COX-2 enzyme.

### GAT Architecture

```
â”Œâ”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”
â”‚                    MULTI-TASK GAT ARCHITECTURE                              â”‚
â”œâ”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”¤
â”‚                                                                             â”‚
â”‚                        INPUT: Molecular Graph                               â”‚
â”‚                               â†“                                             â”‚
â”‚    â”Œâ”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”  â”‚
â”‚    â”‚                   NODE FEATURES (43 dimensions)                    â”‚  â”‚
â”‚    â”‚  â”Œâ”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”    â”Œâ”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”   â”‚  â”‚
â”‚    â”‚  â”‚    RDKit Features (33d) â”‚    â”‚    DFT Features (10d)       â”‚   â”‚  â”‚
â”‚    â”‚  â”‚  â€¢ Element one-hot (10) â”‚    â”‚  â€¢ Mulliken charges         â”‚   â”‚  â”‚
â”‚    â”‚  â”‚  â€¢ Degree one-hot (6)   â”‚    â”‚  â€¢ LÃ¶wdin charges           â”‚   â”‚  â”‚
â”‚    â”‚  â”‚  â€¢ Hybridization (5)    â”‚    â”‚  â€¢ Hirshfeld charges        â”‚   â”‚  â”‚
â”‚    â”‚  â”‚  â€¢ Valence (6)          â”‚    â”‚  â€¢ Fukui f+, f-, f0         â”‚   â”‚  â”‚
â”‚    â”‚  â”‚  â€¢ Aromaticity (1)      â”‚    â”‚  â€¢ Local electrophilicity   â”‚   â”‚  â”‚
â”‚    â”‚  â”‚  â€¢ Formal charge (1)    â”‚    â”‚  â€¢ Local nucleophilicity    â”‚   â”‚  â”‚
â”‚    â”‚  â”‚  â€¢ Num hydrogens (4)    â”‚    â”‚  â€¢ ESP at nuclei            â”‚   â”‚  â”‚
â”‚    â”‚  â””â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”˜    â””â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”˜   â”‚  â”‚
â”‚    â””â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”˜  â”‚
â”‚                               â†“                                             â”‚
â”‚    â”Œâ”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”  â”‚
â”‚    â”‚                   EDGE FEATURES (5 dimensions)                     â”‚  â”‚
â”‚    â”‚  â€¢ Bond type one-hot (4): Single, Double, Triple, Aromatic        â”‚  â”‚
â”‚    â”‚  â€¢ Mayer bond order (1): DFT-computed bond strength               â”‚  â”‚
â”‚    â””â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”˜  â”‚
â”‚                               â†“                                             â”‚
â”‚    â•”â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•—  â”‚
â”‚    â•‘              GRAPH ATTENTION LAYER 1 (GATv2Conv)                   â•‘  â”‚
â”‚    â•‘         Input: 43d  â†’  Output: 256d (64 Ã— 4 heads)                â•‘  â”‚
â”‚    â•šâ•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•  â”‚
â”‚                               â†“                                             â”‚
â”‚                    BatchNorm â†’ ELU â†’ Dropout(0.1)                          â”‚
â”‚                               â†“                                             â”‚
â”‚    â•”â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•—  â”‚
â”‚    â•‘              GRAPH ATTENTION LAYER 2 (GATv2Conv)                   â•‘  â”‚
â”‚    â•‘         Input: 256d  â†’  Output: 64d (averaged heads)              â•‘  â”‚
â”‚    â•šâ•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•  â”‚
â”‚                               â†“                                             â”‚
â”‚                    BatchNorm â†’ ELU                                         â”‚
â”‚                               â†“                                             â”‚
â”‚    â”Œâ”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”  â”‚
â”‚    â”‚                   GLOBAL MEAN POOLING                              â”‚  â”‚
â”‚    â”‚         Aggregate node embeddings â†’ Graph embedding (64d)          â”‚  â”‚
â”‚    â””â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”˜  â”‚
â”‚                               â†“                                             â”‚
â”‚    â”Œâ”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”  â”‚
â”‚    â”‚                MULTI-TASK PREDICTION HEADS                         â”‚  â”‚
â”‚    â”‚  â”Œâ”€â”€â”€â”€â”€â” â”Œâ”€â”€â”€â”€â”€â” â”Œâ”€â”€â”€â”€â”€â” â”Œâ”€â”€â”€â”€â”€â”€â” â”Œâ”€â”€â”€â”€â”€â”€â” â”Œâ”€â”€â”€â”€â”€â”€â”              â”‚  â”‚
â”‚    â”‚  â”‚ HBA â”‚ â”‚ HBD â”‚ â”‚LogP â”‚ â”‚ Arom â”‚ â”‚ TPSA â”‚ â”‚ Acid â”‚              â”‚  â”‚
â”‚    â”‚  â””â”€â”€â”¬â”€â”€â”˜ â””â”€â”€â”¬â”€â”€â”˜ â””â”€â”€â”¬â”€â”€â”˜ â””â”€â”€â”¬â”€â”€â”€â”˜ â””â”€â”€â”¬â”€â”€â”€â”˜ â””â”€â”€â”¬â”€â”€â”€â”˜              â”‚  â”‚
â”‚    â”‚     â”‚       â”‚       â”‚       â”‚        â”‚        â”‚                   â”‚  â”‚
â”‚    â”‚     â””â”€â”€â”€â”€â”€â”€â”€â”´â”€â”€â”€â”€â”€â”€â”€â”´â”€â”€â”€â”€â”€â”€â”€â”´â”€â”€â”€â”€â”€â”€â”€â”€â”´â”€â”€â”€â”€â”€â”€â”€â”€â”˜                   â”‚  â”‚
â”‚    â”‚                         â†“                                          â”‚  â”‚
â”‚    â”‚            Each: Linear(64â†’32) â†’ ReLU â†’ Linear(32â†’1)              â”‚  â”‚
â”‚    â””â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”˜  â”‚
â”‚                                                                             â”‚
â””â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”˜
```

### Understanding Attention Weights

The **attention mechanism** is what makes GAT interpretable. It learns to assign different importance to different neighboring atoms.

#### Mathematical Formulation

For atom $i$ with neighbors $\mathcal{N}(i)$, the attention coefficient between atoms $i$ and $j$ is:

$$\alpha_{ij} = \frac{\exp(\text{LeakyReLU}(\mathbf{a}^T[\mathbf{W}\mathbf{h}_i \| \mathbf{W}\mathbf{h}_j \| \mathbf{e}_{ij}]))}{\sum_{k \in \mathcal{N}(i)} \exp(\text{LeakyReLU}(\mathbf{a}^T[\mathbf{W}\mathbf{h}_k \| \mathbf{W}\mathbf{h}_i \| \mathbf{e}_{ik}]))}$$

Where:
- $\mathbf{h}_i, \mathbf{h}_j$ = node feature vectors
- $\mathbf{e}_{ij}$ = edge features (bond order)
- $\mathbf{W}$ = learnable weight matrix
- $\mathbf{a}$ = attention weight vector

#### Atom Importance Calculation

```
â”Œâ”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”
â”‚                     ATTENTION â†’ ATOM IMPORTANCE                             â”‚
â”œâ”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”¤
â”‚                                                                             â”‚
â”‚   1. Forward pass with return_attention=True                               â”‚
â”‚                      â†“                                                      â”‚
â”‚   2. Get attention weights Î±_ij for all edges                              â”‚
â”‚                      â†“                                                      â”‚
â”‚   3. For each atom i, aggregate incoming attention:                        â”‚
â”‚                                                                             â”‚
â”‚      Importance(i) = Î£ Î±_ji   (sum over all j pointing to i)              â”‚
â”‚                      jâ†’i                                                    â”‚
â”‚                      â†“                                                      â”‚
â”‚   4. Normalize to [0, 1] range                                             â”‚
â”‚                      â†“                                                      â”‚
â”‚   5. Map to molecular visualization                                        â”‚
â”‚                                                                             â”‚
â”‚   Example Output:                                                           â”‚
â”‚   â”Œâ”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”  â”‚
â”‚   â”‚  Atom 0 (C):  â–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–‘â–‘  0.78  â† High importance (aromatic carbon) â”‚  â”‚
â”‚   â”‚  Atom 1 (C):  â–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–‘â–‘â–‘â–‘  0.62                                      â”‚  â”‚
â”‚   â”‚  Atom 2 (N):  â–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–‘  0.91  â† Highest (H-bond acceptor)         â”‚  â”‚
â”‚   â”‚  Atom 3 (O):  â–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–‘â–‘  0.85  â† High (carboxylic acid)            â”‚  â”‚
â”‚   â”‚  Atom 4 (C):  â–ˆâ–ˆâ–ˆâ–ˆâ–‘â–‘â–‘â–‘â–‘â–‘  0.41                                      â”‚  â”‚
â”‚   â””â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”˜  â”‚
â”‚                                                                             â”‚
â””â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”˜
```

### DFT Feature Integration

**Density Functional Theory (DFT)** calculations provide quantum mechanical properties at atomic resolution:

| DFT Feature | Chemical Meaning | Drug Discovery Value |
|-------------|------------------|----------------------|
| **Mulliken Charges** | Electron density distribution | Electrostatic interactions |
| **Fukui f+** | Susceptibility to nucleophilic attack | Metabolic liability |
| **Fukui f-** | Susceptibility to electrophilic attack | Reactive site ID |
| **Local Electrophilicity** | Electron-accepting tendency | Covalent inhibitor design |
| **ESP at Nuclei** | Electrostatic potential | H-bonding prediction |
| **Mayer Bond Order** | Quantum bond strength | Bond stability |

### COX-2 Binding Site Pharmacophore

The binding score is calculated based on **COX-2 structural requirements** (PDB: 4PH9):

```
â”Œâ”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”
â”‚                    COX-2 BINDING SITE PHARMACOPHORE                         â”‚
â”œâ”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”¤
â”‚                                                                             â”‚
â”‚   â”Œâ”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”  â”‚
â”‚   â”‚                     BINDING POCKET                                   â”‚  â”‚
â”‚   â”‚                                                                      â”‚  â”‚
â”‚   â”‚         Arg120 â”€â”€â”€â”€â”€â”                                               â”‚  â”‚
â”‚   â”‚         (salt bridge)â”‚     â”Œâ”€â”€â”€â”€â”€ Tyr385                            â”‚  â”‚
â”‚   â”‚                      â”‚     â”‚      (Ï€-stacking)                      â”‚  â”‚
â”‚   â”‚                      â–¼     â–¼                                        â”‚  â”‚
â”‚   â”‚                   â•”â•â•â•â•â•â•â•â•â•â•â•â•—                                     â”‚  â”‚
â”‚   â”‚      Tyr355 â”€â”€â”€â”€â”€â–¶â•‘  LIGAND   â•‘â—€â”€â”€â”€â”€â”€ Trp387                       â”‚  â”‚
â”‚   â”‚      (H-bond)     â•šâ•â•â•â•â•â•â•â•â•â•â•â•       (Ï€-stacking)                  â”‚  â”‚
â”‚   â”‚                      â–²     â–²                                        â”‚  â”‚
â”‚   â”‚                      â”‚     â”‚                                        â”‚  â”‚
â”‚   â”‚         Ser530 â”€â”€â”€â”€â”€â”˜     â””â”€â”€â”€â”€â”€ Hydrophobic                        â”‚  â”‚
â”‚   â”‚         (H-bond)                  Pocket                            â”‚  â”‚
â”‚   â”‚                                                                      â”‚  â”‚
â”‚   â””â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”˜  â”‚
â”‚                                                                             â”‚
â”‚   PHARMACOPHORE REQUIREMENTS:                                               â”‚
â”‚   â”Œâ”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”¬â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”¬â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”  â”‚
â”‚   â”‚ Feature             â”‚ Optimal Range   â”‚ Biological Rationale        â”‚  â”‚
â”‚   â”œâ”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”¼â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”¼â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”¤  â”‚
â”‚   â”‚ Acidic Group        â”‚ Present         â”‚ Salt bridge with Arg120     â”‚  â”‚
â”‚   â”‚ H-Bond Acceptors    â”‚ 1-6             â”‚ Tyr355, Ser530 interactions â”‚  â”‚
â”‚   â”‚ H-Bond Donors       â”‚ 0-4             â”‚ Hydrogen bond network       â”‚  â”‚
â”‚   â”‚ LogP                â”‚ 1.0-5.5         â”‚ Hydrophobic pocket fit      â”‚  â”‚
â”‚   â”‚ Aromatic Rings      â”‚ 1-4             â”‚ Ï€-stacking with Tyr385      â”‚  â”‚
â”‚   â”‚ Molecular Weight    â”‚ 150-600 Da      â”‚ Binding pocket size         â”‚  â”‚
â”‚   â”‚ TPSA                â”‚ 20-140 Ã…Â²       â”‚ Membrane permeability       â”‚  â”‚
â”‚   â”‚ Rotatable Bonds     â”‚ â‰¤ 10            â”‚ Entropic penalty            â”‚  â”‚
â”‚   â””â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”´â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”´â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”˜  â”‚
â”‚                                                                             â”‚
â”‚   SCORING FORMULA:                                                          â”‚
â”‚                                                                             â”‚
â”‚   Score = Î£(wáµ¢ Ã— sáµ¢) / Î£wáµ¢                                                 â”‚
â”‚                                                                             â”‚
â”‚   Where sáµ¢ âˆˆ [0,1] is the criterion score and wáµ¢ is its weight            â”‚
â”‚                                                                             â”‚
â””â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”˜
```

---

## ğŸ›ï¸ Interactive Dashboards

### DrugQuest Dashboard

The **DrugQuest Dashboard** is a comprehensive 7-tab analysis suite for COX-2 binding prediction results.

#### Dashboard Tabs

**1. Rankings Tab**
- Molecule scoring with adjustable weights
- Visual score bars
- Quick molecule selection

![DrugQuest Rankings](assets/drugquest_rankings.png)

**2. Overview Tab**
- Molecular structure with highlighted atoms
- Atom importance bar chart
- Property radar comparison
- Importance category summary (High/Medium/Low)

![DrugQuest Overview](assets/drugquest_overview.png)

**3. Chemistry Tab**
- Fragment importance analysis
- Functional group detection
- COX-2 binding site context
- Fragment/functional group counts

![DrugQuest Chemistry](assets/drugquest_chemistry.png)

**4. Properties Tab**
- Detailed property analysis
- Target comparison charts
- Drug-likeness assessment

**5. Atom Table Tab**
- Per-atom importance scores
- Element-wise breakdown
- Sortable data table

**6. Breakdown Tab**
- Score component visualization
- Weight contribution pie chart
- Detailed pass/fail status

![DrugQuest Breakdown](assets/drugquest_breakdown.png)

**7. Structure Tab**
- Scaffold analysis
- Scaffold frequency charts
- Scaffold performance comparison
- Molecular substructure images

![DrugQuest Structure](assets/drugquest_structure.png)

### GAT-Specific Analysis Dashboard

The **GAT-Specific Analysis Dashboard** provides deep insights into the Graph Attention Network's learning.

#### Dashboard Tabs

**1. Attention Flow Tab**
- Layer-wise attention visualization
- Multi-head attention comparison
- Edge thickness = attention weight

![GAT Attention Flow](assets/gat_dashboard_attention.png)

**2. Edge Heatmap Tab**
- Attention weight matrix
- Source-target atom relationships
- Clustering patterns

**3. Layer Compare Tab**
- Layer 1 vs Layer 2 attention
- Information flow analysis

**4. Feature Attribution Tab**
- DFT feature importance
- Per-feature contribution scores

**5. DFT Deep Dive Tab**
- Atomwise DFT feature visualization
- Charge distribution maps
- Fukui index analysis

**6. Network View Tab**
- Combined network visualization
- Node size = atom importance
- Edge width = Mayer bond order
- Edge color = combined importance

![GAT Network View](assets/gat_dashboard_network.png)

---

## ğŸ“¦ Installation

### Prerequisites

- Python 3.9+
- CUDA (optional, for GPU acceleration)

### Quick Start

```bash
# Clone repository
git clone https://github.com/yourusername/drug-discovery-suite.git
cd drug-discovery-suite

# Create conda environment
conda create -n drugdiscovery python=3.9
conda activate drugdiscovery

# Install PyTorch (CPU)
pip install torch torchvision torchaudio

# Or for CUDA 11.8
pip install torch torchvision torchaudio --index-url https://download.pytorch.org/whl/cu118

# Install PyTorch Geometric
pip install torch_geometric

# Install other dependencies
pip install rdkit pandas numpy matplotlib seaborn py3Dmol ipywidgets plotly scikit-learn

# Install Jupyter
pip install jupyter jupyterlab
```

### Verify Installation

```python
import torch
import torch_geometric
from rdkit import Chem
import py3Dmol

print(f"PyTorch: {torch.__version__}")
print(f"PyG: {torch_geometric.__version__}")
print(f"CUDA: {torch.cuda.is_available()}")
```

---

## ğŸš€ Usage

### Running the Screening Pipeline

```bash
jupyter notebook drug_screening-5.ipynb
```

1. Run all cells sequentially
2. Use the Interactive Property Filter to set thresholds
3. Click "Apply Filters" to filter molecules
4. Explore results in the Drug Screener Dashboard

### Running the GAT Pipeline

```bash
jupyter notebook gat_multitask_binding.ipynb
```

1. Run all cells to train the model
2. Explore attention patterns in the GAT Dashboard
3. Analyze binding scores in the DrugQuest Dashboard

---

## ğŸ“ˆ Results

### Screening Pipeline Performance

| Metric | Value |
|--------|-------|
| Initial Dataset | 185 molecules |
| Lipinski Compliant | 166 (89.7%) |
| Lead-like | 98 (53.0%) |
| Top Consensus Hits | See notebook |

### GAT Model Performance

| Metric | Value |
|--------|-------|
| Training Molecules | 148 |
| Validation Molecules | 37 |
| Best Val Loss | ~0.15 |
| Tasks | 6 (HBA, HBD, LogP, Aromatic, TPSA, Acid) |

### Top COX-2 Candidates

| Rank | Molecule | Binding Score |
|------|----------|---------------|
| 1 | Diclofenac | 0.968 |
| 2 | Piroxicam | 0.945 |
| 3 | Perindopril | 0.943 |
| 4 | Ramipril | 0.933 |
| 5 | Valsartan | 0.933 |

---


## ğŸ¤ Contributing

Contributions are welcome! Please feel free to submit a Pull Request.

1. Fork the repository
2. Create your feature branch (`git checkout -b feature/AmazingFeature`)
3. Commit your changes (`git commit -m 'Add some AmazingFeature'`)
4. Push to the branch (`git push origin feature/AmazingFeature`)
5. Open a Pull Request

---

## ğŸ“œ License

This project is licensed under the MIT License - see the [LICENSE](LICENSE) file for details.

---

## ğŸ“š References

1. Lipinski, C.A. et al. (1997). Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings. *Adv. Drug Deliv. Rev.*
2. VeliÄkoviÄ‡, P. et al. (2018). Graph Attention Networks. *ICLR 2018*
3. Brody, S. et al. (2022). How Attentive are Graph Attention Networks? *ICLR 2022*
4. Bickerton, G.R. et al. (2012). Quantifying the chemical beauty of drugs. *Nat. Chem.*

---

## ğŸ“§ Contact

**Author**: Mayukh Sarkar

---

<p align="center">
  <i>Built with â¤ï¸ for computational drug discovery</i>
</p>
